Clinical Pharmacokinetics and Practical Applications of Simvastatin
- 1 March 1993
- journal article
- review article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 24 (3), 195-202
- https://doi.org/10.2165/00003088-199324030-00002
Abstract
Since simvastatin is metabolised by the cytochrome P450 system, a potential for drug interactions exists. Elevated HMG-CoA reductase inhibitory activity has been observed when simvastatin was...Keywords
This publication has 30 references indexed in Scilit:
- Comparative Pharmacokinetics of Lovastatin, Simvastatin and Pravastatin in HumansThe Journal of Clinical Pharmacology, 1992
- Low-dose simvastatin for the treatment of hypercholesterolaemia in recipients of cardiac transplantationInternational Journal of Cardiology, 1991
- Relative Lipophilicities, Solubilities, and Structure–Pharmacological Considerations of 3-Hydroxy-3-Methylglutaryl-Coenzyme A (HMG-CoA) Reductase Inhibitors Pravastatin, Lovastatin, Mevastatin, and SimvastatinJournal of Pharmaceutical Sciences, 1991
- SimvastatinDrugs, 1990
- Tissue selectivity of the cholesterol-lowering agents lovastatin, simvastatin and pravastatin in rats in vivoBiochemical and Biophysical Research Communications, 1989
- Efficacy and long-term adverse effect pattern of lovastatinThe American Journal of Cardiology, 1988
- HMG-CoA Reductase Inhibitors for Treatment of HypercholesterolemiaNew England Journal of Medicine, 1988
- Simvastatin (MK-733): a potent cholesterol synthesis inhibitor in heterozygous familial hypercholesterolaemiaAtherosclerosis, 1988
- Effectiveness of mevinolin on plasma lipoprotein concentrations in type II hyperlipoproteinemiaThe American Journal of Cardiology, 1986
- Hypocholesterolemic effects of mevinolin in patients with heterozygous familial hypercholesterolemia.Journal of Clinical Investigation, 1984